A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Recruiting

Phase 2

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTA Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Sponsor:

Children's Oncology Group

Code:

NCT04684368

Conditions

Central Nervous System Nongerminomatous Germ Cell Tumor

Choriocarcinoma

Embryonal Carcinoma

Immature Teratoma

Malignant Teratoma

Eligibility Criteria

Sex: All

Age: 3 - 29

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Etoposide

Filgrastim

Ifosfamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-03-25.